| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 27, 2026 | Avante Raises $30 Million Series A Led By Frist Cressey Ventures | Avante has raised $30 million in Series A funding to expand its enterprise AI platform for employee benefits teams. Frist Cressey Ventures led the round, with participation from Sorenson Capital, Hearst Ventures, Morgan Stanley Next Level F... |
| Jul 14, 2026 | Real Chemistry Launches Real Chemistry ANATOMI, an AI Ecosystem Purpose-Built for Healthcare Commercialization | Real Chemistry, a global leader in AI-driven insights and marketing and communications exclusively for the healthcare and life sciences sectors, today announced the launch of Real Chemistry ANATOMI, an ecosystem of AI solutions purpose-buil... |
| Jun 18, 2026 | Real Chemistry Unifies Omnichannel Offering as Real Chemistry Media, a Technology-led, Healthcare-focused Practice of the Future | Real Chemistry, a leader in AI-driven insights and marketing and communications exclusively for the healthcare and life sciences sectors, today announced the full integration of Spring & Bond, Greater Than One, and its legacy media and ... |
| May 28, 2026 | Real Chemistry Appoints Healthcare Industry Leaders Frank Clyburn and Chris Fikry to Board of Directors | Real Chemistry, a leader in AI-driven insights and marketing and communications exclusively for the healthcare and life sciences sectors, today announced the appointments of two non-executive board members, Frank Clyburn and Christopher (Ch... |
| May 12, 2026 | Cerevance Completes Enrollment in Pivotal Phase 3 Parkinson’s Disease Trial and Closes Oversubscribed $20 Million Series C to Extend Runway into 2027 | Boston – MAY 12, 2026 – Cerevance, a clinical-stage biopharmaceutical company advancing targeted therapies for neurodegenerative diseases and obesity, today announced completion of patient enrollment in the pivotal Phase 3 ARISE trial evalu... |
| Mar 2, 2026 | Real Chemistry Delivers Double-Digit Year-Over-Year Growth in 2025 as Tier-One, Tech-Enabled Healthcare Commercialization Partner | Real Chemistry today announced results for the fiscal year ending December 31, 2025, underscoring sustained momentum and reinforcing the company’s position as a commercialization partner to the world’s most innovative life sciences and heal... |
| Feb 5, 2026 | Real Chemistry Strengthens Global Presence with New International Leadership Appointments and Expanded Regional Hubs | Real Chemistry, a global leader in AI- and insights-driven healthcare communications, today provided an update on the company’s global growth strategy with the appointment of four senior international leaders and an expanded regional hub pr... |
| Jan 20, 2026 | Colgate-Palmolive and WHO Foundation Announce Global Partnership on Oral Health | Today, Colgate-Palmolive announced a new multi-year collaboration with the WHO Foundation to support the World Health Organization’s work on oral health. The four-year funding commitment will help expand oral health education, support integ... |
| Jan 9, 2026 | Real Chemistry Establishes RC Resolve, an Advisory Practice for Healthcare’s Most Critical Business, Regulatory and Value Inflection Points | Real Chemistry today announced the launch of RC Resolve, a healthcare advisory practice designed to help leaders navigate the value inflection points where science, business, economics, policy and risk management intersect. RC Resolve offer... |
| Aug 25, 2025 | Real Chemistry Launches Healthcare-First AI Search Solution | Real Chemistry, a leader in AI-driven insights and marketing communications for the healthcare sector, today announced the launch of HealthGEO – an AI search solution purpose-built for life sciences communicators and marketers, helping team... |
| Sep 18, 2024 | The Evolution of Oncology: A New Era in Cancer Treatment | The landscape of oncology is changing. Rapid advancements in drug development are reshaping how we approach cancer treatment. The recent European Society for Medical Oncology (ESMO) 2024 annual meeting showcased this transformation. The spo... |
| Sep 18, 2024 | FINN Partners Appoints Julie Adrian for Growing Agency’s UK Health Group | FINN Partners, one of the world’s leading independent marketing and communications agencies, today announces the appointment of Julie Adrian as Managing Partner and UK Health Group Lead. In the newly created position, Adrian reports to Gil ... |
| Jun 10, 2024 | PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep Apnea and Comorbid Insomnia | SAN DIEGO, June 10, 2024 (GLOBE NEWSWIRE) -- In collaboration with leading medical researchers from around the world, ResMed (NYSE: RMD, ASX: RMD) presented 13 new clinical studies at SLEEP 2024, the annual joint meeting of the American Aca... |
| Jun 10, 2024 | PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep Apnea and Comorbid Insomnia | ResMed studies presented at SLEEP 2024 also revealed a 17% prevalence of insomnia among adults in North America, Latin America, and the Caribbean, and a higher rate of depression in women with OSA
SAN DIEGO, June 10, 2024 (GLOBE NEWSWIRE) -... |
| May 28, 2024 | Chicory Expands Leadership Team With First Chief Financial Officer Hire | Stacey Hafers, who led exits at TI Health and Crisp Media, brings 25 years of experience to role
NEW YORK, May 28, 2024 /PRNewswire/ -- Chicory, the leading contextual commerce advertising platform, has named Stacey Hafers as its first chie... |
| Apr 26, 2024 | Highwire PR announces appointment of Two Independent Board Members | Adam Cossman and Dave Samson bring proven track records and expertise in key growth areas for Highwire, including healthcare, digital, analytics and corporate communications
Highwire PR, a high-impact communications and marketing partner fo... |
| Apr 2, 2024 | NATION'S FASTEST GROWING HEALTHCARE MARKETING AND COMMUNICATIONS FIRM EXPANDS TO SUPPORT INNOVATORS TRANSFORMING U.S. HEALTHCARE | 120/80 GROUP Invests to Serve New Markets Propelled by Artificial Intelligence
Agency Adds Strategic Leadership, Launches New Brand, Expands Services
NEW YORK AND SAN JOSE, Calif., April 2, 2024 /PRNewswire/ -- Marking five years of unprece... |
| Sep 7, 2023 | Derivative works are generative AI’s poison pill | Simeon Simeonov Contributor
Share on X
Simeon Simeonov is the CTO of Real Chemistry, which combines advanced AI with deep human insights to improve healthcare and patient outcomes.
May Habib Contributor
Share on X
May Habib is CEO and co-fo... |
| Aug 10, 2023 | Real Chemistry and WhizAI Debut Generative AI-Based Patient Journey Visualization and Analytics Solution | Solution provides accurate and contextual insights for better patient outcomes
Real Chemistry, a leading provider of AI-driven insights and marketing and communications for the healthcare industry, announced a strategic partnership with Whi... |
| Jul 22, 2023 | Daily AI Roundup: Biggest Machine Learning, Robotic And Automation Updates 22nd July 2023 | This is our AI Daily Roundup . We are covering the top updates from around the world. The updates will feature state-of-the-art capabilities in artificial intelligence (AI), Machine Learning, Robotic Process Automation, Fintech, and human-s... |
| Jul 21, 2023 | Real Chemistry Enters Enterprise Partnership with Writer to Expand Use of Generative AI to Benefit Healthcare Clients | Company Puts Generative AI Tools to Work to Enhance Capabilities and Drive Innovation in a Secure and Private Environment
Real Chemistry, the leading provider of AI-driven insights and marketing and communications for the healthcare industr... |
| Jun 24, 2023 | Jobs are now requiring experience with ChatGPT — and they'll pay as much as $800,000 a year for the skill | Here are the 9 types of roles companies are hiring for that require AI chatbot expertise. Hannes P Albert/Picture Alliance via Getty Images
Experience with OpenAI's ChatGPT could help you land your next job.
Insider reviewed dozens of ... |
| May 5, 2023 | Carisma Therapeutics to Present at Upcoming Healthcare Industry Conferences in May 2023 | PHILADELPHIA, May 5, 2023 /PRNewswire/ -- Carisma Therapeutics Inc. CARM ("Carisma"), a clinical stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that the company wi... |
| Mar 2, 2023 | Real Chemistry Acquires Leading HCP Engagement Company TI Health | Advertising technology company will be integrated into Swoop, creating a unified HCP and DTC system of engagement for healthcare marketers Growth expands Real Chemistry’s capabilities and technology offerings
Real Chemistry, the leading pro... |
| Feb 14, 2023 | 16 Things Pop Culture Gets Wrong About Artificial Intelligence | Tech experts are sold on the benefits of leveraging artificial intelligence to help humans handle cumbersome and sometimes complex tasks in applications ranging from business to healthcare to education and entertainment—and beyond. And whil... |
| Nov 11, 2022 | Carisma Therapeutics Announces Clinical & Pre-Clinical Updates | New data from Phase 1 clinical trial of CT-0508 presented at SITC
Early pre-clinical data on CT-1119 and preliminary insights from novel immunotherapy platform also presented
PHILADELPHIA, Nov. 11, 2022 /PRNewswire/ -- Carisma Therapeutics ... |
| Sep 21, 2022 | 4BIO Capital Portfolio Company Carisma Therapeutics and Sesen Bio Announce Merger Agreement | 21 September 2022 |
| Aug 17, 2022 | Kronos Bio and Invivoscribe Partner on Companion Diagnostic for Use with Entospletinib, Kronos Bio's Investigational Compound Being Developed for Patients with AML | Companion diagnostic would be used following potential regulatory approval of entospletinib to screen for NPM1 mutation present in approximately one-third of all patients with AML
Entospletinib is currently being studied in the Phase 3 AGIL... |
| Feb 10, 2022 | Indapta Therapeutics Names Mark W. Frohlich, M.D., Chief Executive Officer and Raises Over $50 Million in Series A Financing and Commitments to Advance Development of G-NK Cell Therapy to Treat Multiple Types of Cancer | – Former Juno Therapeutics and Dendreon executive brings expertise and track record in cell therapy drug development –
– Financing led by RA Capital Management, LP, Vertex Ventures HC and Leaps By Bayer with the Myeloma Investment Fund and ... |
| Sep 16, 2021 | Syapse Awarded 2021 Technology Innovation Leadership Award by Frost & Sullivan for Accelerating Real-world Care Delivery | Syapse's three-pronged approach offers a complete service cycle, helping health systems, providers, and life science organizations to improve cancer care quality
SANTA CLARA, Calif., Sept. 16, 2021 /PRNewswire/ -- Based on its recent a... |
| Aug 9, 2021 | 16 Big Challenges Facing Tech Teams (And How To Solve Them) | Covid-19 has tested professionals across industries, but none more so than tech teams. On top of their usual loads, tech teams in many companies were tasked with developing and overseeing plans for their colleagues to seamlessly shift to re... |
| Mar 22, 2021 | The W2O Center for Social Commerce at Syracuse University’s S.I. Newhouse School of Public Communications Releases Signature Research Study on the College Experience During COVID-19 | SYRACUSE, N.Y.--(BUSINESS WIRE)--Mar 22, 2021--
The W2O Center for Social Commerce (CSC), a leading partnership between the S.I. Newhouse School of Public Communications at Syracuse University (SU) and W2O – an analytics-oriented, insight-d... |
| Mar 18, 2021 | CARISMA Therapeutics Announces First Patient Dosed in Landmark Clinical Study Evaluating Engineered Macrophages in Humans | PHILADELPHIA, March 18, 2021 /PRNewswire/ -- CARISMA Therapeutics Inc., a clinical stage biopharmaceutical company spun out of the University of Pennsylvania (Penn) and focused on discovering and developing innovative immunotherapies, annou... |
| W2O Becomes Real Chemistry, a Global Health Innovation Company Designed to Improve Outcomes Across Today’s Healthcare Ecosystem | SAN FRANCISCO--(BUSINESS WIRE)--Mar 10, 2021--
W2O, the healthcare marketing and communications powerhouse founded 20 years ago by Jim Weiss, announced today that it has transformed into a new kind of healthcare company named Real Chemistry... |
